Skip to content
Simpler Grants

No. HT942526ATRPTRA · Defense Health Agency Contracting Activity - DHACA

Open

DoW Arthritis Translational Research Award

grants.gov listing Full announcement (NOFO)
Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated
Invitation only
“Invitation to Submit an Application: August 27,2026” — From the announcement
Award range
Not specified
Expected awards
~2
Application deadline
Oct 22, 2026
Posted
May 1, 2026
Last verified
2 days ago

At a glance

AI summary

The Arthritis Translational Research Award funds high-impact translational and preclinical research on arthritis that is meant to move findings toward clinically relevant solutions. It is open to eligible U.S. Department of War organizations, including intramural and extramural, domestic and foreign, for-profit and nonprofit, and public or private entities; independent investigators at eligible organizations may serve as principal investigator. The program expects about $1.6 million total to fund about two awards, with a total cost cap of $800,000 per award and a maximum performance period of 3 years. Cost sharing is not required. Clinical trials and basic research are not allowed, and applications must fit one of the listed focus areas and arthritis types.

AI-generated summary — verify against the announcement

What it funds

  • Science and Technology and other Research and Development
  • Research & Discovery
  • Veterans, Military & Public-Safety Personnel
  • Biomedical & Disease Research
  • Defense, National Security & Aerospace
Official description from grants.gov

Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Translational Research Award (TRA) supports high-impact translational research that will accelerate critical findings into clinically relevant solutions. Research funded under this award mechanism will be hypothesis-driven, high-impact applied research that is relevant to Service Members, Veterans, their Families and the American public. Research addressing any and all types of arthritis is encouraged. Distinctive Features: The FY26 ATRP TRA mechanism is intended to support preclinical or animal research and may not be used for clinical research or clinical trials. Basic research, as defined in Section 3.1.2, is not allowed. A key aspect of this award mechanism is impact. The application should explicitly state how outcomes of the proposed research will significantly advance arthritis research, particularly in accelerating critical findings into clinically relevant solutions. Preliminary and/or published data, originating from research conducted by the applicant(s) or others, is required.

Who can apply

  • Unrestricted
Geographic restriction None found in the announcement — likely nationwide

Program history

USASpending.gov

Assistance listing 12.420 · Military Medical Research and Development

Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.

Fiscal year Awards Median award Middle half
FY 2026 (so far) 374 $934,195 $559,998 – $1,477,811
FY 2025 967 $796,174 $416,995 – $1,480,602
FY 2024 1,097 — —
FY 2023 1,115 — —
FY 2022 1,186 — —
FY 2021 1,023 — —

Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.

Who wins it Business (127), Nonprofit (34), Higher education (2) of 5,762 awards — categories can overlap.
Top states CA (135) · TX (103) · NY (99) · MA (74) · MD (38)
Largest recent awards
  1. THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
  2. H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
  3. UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
  4. SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
  5. UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025

Source: USASpending.gov · refreshed Aug 25, 2026